Labiana Health Future Growth

Future criteria checks 5/6

Labiana Health is forecast to grow earnings and revenue by 98.9% and 10.1% per annum respectively. EPS is expected to grow by 97.6% per annum. Return on equity is forecast to be 37.8% in 3 years.

Key information

98.9%

Earnings growth rate

97.6%

EPS growth rate

Pharmaceuticals earnings growth	25.7%
Revenue growth rate	10.1%
Future return on equity	37.8%
Analyst coverage	Low
Last updated	18 Nov 2024

Recent future growth updates

Recent updates

Labiana Health (BME:LAB) Has No Shortage Of Debt

Nov 18

Is Labiana Health (BME:LAB) Weighed On By Its Debt Load?

Jun 08

Earnings and Revenue Growth Forecasts

BME:LAB - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	84	4	3	12	2
12/31/2025	74	2	1	8	2
12/31/2024	66	1	4	6	2
6/30/2024	66	-1	-4	-2	N/A
3/31/2024	63	-3	-4	-2	N/A
12/31/2023	60	-4	-4	-2	N/A
9/30/2023	60	-7	0	4	N/A
6/30/2023	60	-10	4	9	N/A
3/31/2023	60	-9	2	7	N/A
12/31/2022	61	-9	-1	5	N/A
12/31/2021	59	-2	-1	4	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LAB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).

Earnings vs Market: LAB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: LAB is expected to become profitable in the next 3 years.

Revenue vs Market: LAB's revenue (10.1% per year) is forecast to grow faster than the Spanish market (5% per year).

High Growth Revenue: LAB's revenue (10.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: LAB's Return on Equity is forecast to be high in 3 years time (37.8%)

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/19 14:23
End of Day Share Price	2024/12/19 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Labiana Health, S.A. is covered by 1 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Luis Esteban Arribas	Lighthouse-IEAF Servicios de Analisis